ESR2 and colorectal carcinoma: Our findings indicate that E2 may also have a pro-tumorigenic role in certain hypoxic microenvironments (for example, deep within a tumor), emphasizing the importance of research into GPER-specific ligands in CRC treatment for ERβ negative patients and in hypoxic tumors.